Investor seeks access to Bio-Rad books
An investor in life sciences company Bio-Rad, which agreed a US$55 million FCPA-related non-prosecution agreement with the US Department of Justice and the Securities and Exchange Commission in November, has asked the Delaware Chancery Court to force the company to turn over records related to the foreign bribery allegations.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.